chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Dry mouth, Feeling hot, Headache, Inappropriate schedule of product administration
Clinical narrative: Within 3 hours headache.; Within 30 min: Warm sensation from left cheek down left arm.; Inappropriate schedule of vaccine administered; Joint pain; Significant body aches; Lethargy; Dry mouth; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151), via an unspecified route of administration in the left arm on 06Apr2021 at 15:00 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. Medical history included hypertension. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), hydrochlorothiazide (MANUFACTURER UNKNOWN) and omeprazole (MANUFACTURER UNKNOWN); all from an unknown date for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613), via an unspecified route of administration in the left arm on 19Mar2021 at 15:00 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. The patient previously took augmentin (MANUFACTURER UNKNOWN) on unknown date for an unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 15:30, within 30 min the patient experienced warm sensation from left cheek down left arm. Within 3 hours headache. Within 12-18 hours post: dry mouth, significant body aches, joint pain, headache and lethargy. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events warm sensation from left cheek down left arm, headache, dry mouth, significant body aches, joint pain, headache and lethargy were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Lethargy, Pain
Clinical narrative: Within 3 hours headache.; Within 30 min: Warm sensation from left cheek down left arm.; Inappropriate schedule of vaccine administered; Joint pain; Significant body aches; Lethargy; Dry mouth; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151), via an unspecified route of administration in the left arm on 06Apr2021 at 15:00 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. Medical history included hypertension. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), hydrochlorothiazide (MANUFACTURER UNKNOWN) and omeprazole (MANUFACTURER UNKNOWN); all from an unknown date for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613), via an unspecified route of administration in the left arm on 19Mar2021 at 15:00 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. The patient previously took augmentin (MANUFACTURER UNKNOWN) on unknown date for an unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 15:30, within 30 min the patient experienced warm sensation from left cheek down left arm. Within 3 hours headache. Within 12-18 hours post: dry mouth, significant body aches, joint pain, headache and lethargy. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events warm sensation from left cheek down left arm, headache, dry mouth, significant body aches, joint pain, headache and lethargy were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Feeling abnormal, Heart rate, Hypoaesthesia, Paraesthesia oral
Clinical narrative: Exactly 20 minutes post-vaccination. Tongue felt odd like swelling; Exactly 20 minutes post-vaccination. Tongue felt odd like swelling, then left side of face to include ear and below left eye, upper and lower jaw affected (left side only). (Odd numbness)Complete left; (Odd numbness)Complete left side of face; Very little tingling in left side lower lip.; Still have some lingering weird feeling 3hr 45mins later.; This is a spontaneous report from a contactable nurse. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729), via an unspecified route of administration in the left arm on 07Apr2021 at 10:30 (at the age of 49-years-old), as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Concomitant medications included zinc oxide (ZINC) from unknown date for unspecified indication and daily vitamin from unknown date for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 10:50, exactly 20 minutes post-vaccination, the patient experienced tongue felt odd like swelling, then left side of face to include ear and below left eye, upper and lower jaw affected left side only, odd numbness complete left side of face felt as if the patient had been injected by the dentist with lidocaine, very little tingling in left side lower lip which started to subside about 2 hours later, still have some lingering weird feeling 3hr 45 mins later. The events did not result in doctor or other healthcare professional office/clinic visit or emergency visit. No therapeutic measures were taken as a result of the reported events. On an unknown date, the patient underwent blood pressure test and the result was normal. On 07Apr2021, the patient underwent lab test and procedures which included BP, RR, HR and the results were found to be normal. The clinical outcome of the event very little tingling in left side lower lip was recovered on 07Apr2021 at 12:45. The clinical outcome of the events tongue felt odd like swelling, then left side of face to include ear and below left eye, upper and lower jaw affected (left side only), odd numbness complete left side of the face and some lingering weird feeling were unknown at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory rate, Swelling face, Swollen tongue
Clinical narrative: Exactly 20 minutes post-vaccination. Tongue felt odd like swelling; Exactly 20 minutes post-vaccination. Tongue felt odd like swelling, then left side of face to include ear and below left eye, upper and lower jaw affected (left side only). (Odd numbness)Complete left; (Odd numbness)Complete left side of face; Very little tingling in left side lower lip.; Still have some lingering weird feeling 3hr 45mins later.; This is a spontaneous report from a contactable nurse. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729), via an unspecified route of administration in the left arm on 07Apr2021 at 10:30 (at the age of 49-years-old), as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Concomitant medications included zinc oxide (ZINC) from unknown date for unspecified indication and daily vitamin from unknown date for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 10:50, exactly 20 minutes post-vaccination, the patient experienced tongue felt odd like swelling, then left side of face to include ear and below left eye, upper and lower jaw affected left side only, odd numbness complete left side of face felt as if the patient had been injected by the dentist with lidocaine, very little tingling in left side lower lip which started to subside about 2 hours later, still have some lingering weird feeling 3hr 45 mins later. The events did not result in doctor or other healthcare professional office/clinic visit or emergency visit. No therapeutic measures were taken as a result of the reported events. On an unknown date, the patient underwent blood pressure test and the result was normal. On 07Apr2021, the patient underwent lab test and procedures which included BP, RR, HR and the results were found to be normal. The clinical outcome of the event very little tingling in left side lower lip was recovered on 07Apr2021 at 12:45. The clinical outcome of the events tongue felt odd like swelling, then left side of face to include ear and below left eye, upper and lower jaw affected (left side only), odd numbness complete left side of the face and some lingering weird feeling were unknown at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Extreme pain in my left elbow; This is a spontaneous report from a non-contactable consumer, the patient. A 32-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 05Apr2021 at 10:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received dilaudid (MANUFACTURER UNKNOWN) reported as dilauted and morphine (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021, the patient experienced extreme pain in left elbow. The clinical outcome of the event extreme pain in left elbow was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Feeling hot, Parosmia, Taste disorder
Clinical narrative: Terrible reaction as far as taste/bad taste starts in far back of mouth; bad smell/ seems to hang in the nostrils and sinuses; feeling of heat traveling down nostrils; disgusting taste and smell forces to stop eating; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the right arm on 03Mar2021 at 12:30 (at the age of 66-year-old) as a single dose and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 24Mar2021 at 12:45 (at the age of 66-year-old) as a single dose for COVID-19 immunisation. Medical history included neuropathy peripheral since unknown date and penicillin allergy. Concomitant medications included pregabalin (LYRICA) 300 mg daily and doxazosin (MANUFACTURER UNKNOWN) 8 mg daily, all received within two weeks of vaccination for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Mar2021, shortly after first dose, the patient started experiencing a terrible reaction as far as taste in the foods (never had a problem previously) bad taste starts in far back of mouth, then a bad smell became associated with it which seems to hang in the nostrils and sinuses. When the patient continues eating the bad taste and smell, intensify and a feel of heat travelled down to nostrils. The disgusting taste and smell forces patient to stop eating small quantities of food like peanut butter, peanuts and potato chips. After second dose the foods peanut, pretzels, popcorn and tostitos got added. The patient did not receive any treatment for the events. The clinical outcome of the event altered taste, altered smell, feeling of heat and stopped eating was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Lymphadenopathy, Pain, Pain in extremity
Clinical narrative: Mild headache; Body soreness; Fatigue; Mild swelling of lymph nodes; Soreness of right arm; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 06Apr2021 at 12:00 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as no. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) from an unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the right arm on 16Mar2021 at 12:00 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 00:00, the patient experienced mild headache, body soreness, fatigue, mild swelling of lymph nodes and soreness of right arm. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events mild headache, body soreness, fatigue, mild swelling of lymph nodes and soreness of right arm was resolving at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache
Clinical narrative: Mild headache; joint pain; tiredness; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 10:00 (at the age of 55-years-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19 on unknown dates. Concomitant medications were not reported. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07Apr2021 at 13:00, the patient experienced mild headache, joint pain and tiredness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events mild headache, joint pain and tiredness was unknown at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Decreased appetite, Dysgeusia
Clinical narrative: Strong metallic taste in mouth; affects appetite; affects taste of food/drink; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the right arm on 06Apr2021 at 12:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN), naproxen sodium (MANUFACTURER UNKNOWN) and camphor, diphenhydramine hydrochloride, zinc oxide (BENADRYL) taken for unknown indication from an unknown start date within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 13:00, the patient experienced strong metallic taste in mouth that had lasted for 16 hours and was continuing; not debilitating, but affected appetite and taste of food/drink. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events strong metallic taste and affects appetite were not recovered at the time of the report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Head discomfort, Headache
Clinical narrative: heaviness on left side; Headache; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 03Apr2021 at 13:15 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not have a history of allergies to any food or medications or others products. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN) and METFORMIN (MANUFACTURER UNKNOWN) both started on an unknown date for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021, the patient experienced headache and heaviness on left side. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the events. The clinical outcome of the event headache and heaviness on left side was recovered on an unknown date in Apr2021.  No follow-up attempts are needed; information about lot number cannot be obtained. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain
Clinical narrative: Headache; Body aches; Very very tired; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received an an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 23Mar2021 at 17:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, thyroid disorder and Gastroesophageal Reflux Disease (GERD). The patient was allergic mangoes and pectic. Concomitant medications included escitalopram oxalate (LEXAPRO). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received codeine and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Mar2021 at 19:00, the patient experienced headache, body aches and was very very tired. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcomes of the events headache, body aches and very very tired were resolved on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pyrexia, SARS-CoV-2 test
Clinical narrative: intense fatigue; fever; Headache; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP 7533) via an unspecified route of administration in the left arm on 02Apr2021 at 14:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma since unknown date. It was reported that the patient had no allergies to medications, food, or other products. Concomitant medications included escitalopram oxalate (LEXAPRO) 10mg received within two weeks of vaccination for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 18:00, a day after the vaccination, the patient experienced headache. On 04Apr2021, two days after, the patient experienced intense fatigue and fever. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. On 06Apr2021, the patient underwent two nasal swabs and the result of PCR test was pending and negative for other one. The clinical outcome of the events headache, intense fatigue and fever was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Pruritus, Urticaria
Clinical narrative: Diarrhea; Hives all up and down arms and hands, a few on legs; Itched head to toe; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 06Apr2021 at 14:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome, obesity, raynaud's syndrome and known allergy to sulfa drugs. Concomitant medications included escitalopram oxalate (LEXAPRO), colecalciferol (VITAMIN D3), ascorbic acid (VITAMIN C), silybum marianum (MILK THISTLE) and krill oil (KRILLA); all from unknown dates for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 20:00, 6 hours post vaccination, the patient experienced hives all up and down arms and hands, a few on legs and itched head to toe. On 07Apr2021 at 10:00, 20 hours post vaccination, the patient experienced diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events hives all up and down arms and hands, a few on legs, itched head to toe and diarrhea was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 23Mar2021 at 18:00 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history included chickenpox (when the patient was a child) and fruit allergy (mango fruit allergy). Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN), amitriptyline (MANUFACTURER UNKNOWN), pravastatin (MANUFACTURER UNKNOWN), hydrocodone bitartrate and paracetamol (NORCO) from unknown dates taken for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 13:00, the patient experienced breakout of the shingles virus. The event resulted in emergency room/department visit or urgent care, but there was no diagnosis for the rash on face. Therapeutic measures were taken as a result of the event which included treatment with Amoxicillin. On 03Apr2021, the patient again returned to the urgent care as the symptoms were getting worse and they diagnosed the patient with shingles which was confirmed by the urgent care facility. It was stated that the patient has no prior history of shingles. Therapeutic measures were taken as a result of shingles which included treatment with valacyclovir 1 gm tablet AUR three times a day for ten days. The clinical outcome of the event shingles was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pyrexia
Clinical narrative: Fever; severe body aches; chills; headache; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0150) via an unspecified route of administration in the left arm on 06Apr2021 at 00:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. If other medications in two weeks were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 03:00 the patient experienced fever, severe body aches, chills, headache and head kind of swimming. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events fever, severe body aches, chills, headache was not recovered at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Dysgeusia, Taste disorder, Tongue discomfort
Clinical narrative: Severe Bitter taste; Food tastes weird; Burning sensation in the front part of the tongue; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EJ1685) via an unspecified route of administration in the left arm on 19Dec2020 at 07:30 (at the age of 50-years-old), as a single dose for COVID-19 immunisation and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL1284) via an unspecified route of administration in the left arm on 08Jan2021 (at the age of 50-years-old), as a single dose for COVID-19 immunisation. Medical history included hyperlipidemia. The patient had no allergies to medications, food, or other products. Concomitant medications included rosuvastatin (MANUFACTURER UNKNOWN) and herbal glucosamine (MANUFACTURER UNKNOWN), both taken from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Dec2020 at 13:00, the patient experienced severe bitter taste that had lingered on till the time of this report, sometimes mild and sometimes severe, most of all food tastes weird and burning sensation in the front part of the tongue, that comes and goes. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event severe bitter taste, food tastes weird and burning sensation in tongue were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Headache, Migraine
Clinical narrative: earache; Migraine; Headache; This is a spontaneous report from a contactable healthcare professional, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733), via an unspecified route of administration in the right arm on 02Apr2021 at 16:45 (at the age of 37-year-old), as a single dose for COVID-19 immunisation. Medical history included autoimmune inner ear disease, multiple sclerosis and shellfish allergy. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021, the first day, the patient experienced headache and progressed to migraine on the second day (on 04Apr2021), then went away. On 07Apr2021, after 5 days of vaccination, the patient experienced earache. The adverse events headache, earache and migraine resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the event headache and migraine was resolved on an unknown date in Apr2021 while that of the event earache was not resolved.   No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Oral mucosal eruption
Clinical narrative: Rash on the inside of mouth, near lips and on both sides of mouth.; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8737) via an unspecified route of administration in the right arm on 06Apr2021 at 12:00 (at the age of 29-year-old) as a single dose for COVID-19 immunisation.  Medical history included COVID-19. Concomitant medications included  multivitamin (MANUFACTURER UNKNOWN) and fluticasone propionate (FLONASE) from unknown date for unknown indication. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 07:00, the patient experienced rash on the inside of mouth, near lips and on both sides of  mouth. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient received treatment for the reported event which included  lidocaine ointment. The clinical outcome of the events rash on the inside of mouth was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Felt dizzy; This is a spontaneous report from a non-contactable consumer. A 63-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on 06Apr2021 (at the age of 63-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were unknown. The patient did not have allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021, the patient felt dizzy about 3 hours after the vaccination. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the event. The clinical outcome of the event felt dizzy was recovered on an unknown date in 2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Fatigue, Lymph node pain, Lymphadenopathy, Vaccination site swelling
Clinical narrative: Extremly fatigued; Right arm also feels swollen where injected.; Swollen right armpit with lumps. Not sure if they are swollen lymph nodes. Very tender and sore.; Swollen right armpit with lumps. Not sure if they are swollen lymph nodes. Very tender and sore.; Swollen right armpit with lumps. Not sure if they are swollen lymph nodes. Very tender and sore.; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 05Apr2021 at 12:00 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history included Hashimoto's disease. Concomitant medications included vitamin d (MANUFACTURER UNKNOWN) and levothyroxine sodium (LEVOXYL); both from unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 22Mar2021 at 12:00 (at the age of 48-year-old) as a single dose for COVID-19 immunisation and took Codeine and Vicodin; both on unknown date for unspecified indication and experienced drug allergy Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 15:00 within three hours of vaccination, the patient experienced swollen right armpit with lumps and not sure if they are swollen lymph nodes, very tender and sore, right arm also feels swollen where injected and extremely fatigued. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events swollen lymph node, lymph node tenderness, armpit pain, fatigue and vaccination site swelling were not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chest discomfort, Chills, Decreased appetite, Dyspnoea
Clinical narrative: Chills; Muscle pain; Chest pressure; Fatigue; Loss of apetite; Shortness of breath; Joint pain; Headache; Fever; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 24Mar2021 at 12:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation.  Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Mar2021 at 20:00 the patient experienced chills, muscle pain, chest pressure, fatigue, loss of apatite, shortness of breath, joint pain, headache and fever. On 30Mar2021, the patient underwent lab test which included COVID-19 virus test (nasal swab) and the result was found to be negative. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events chills, muscle pain, chest pressure, fatigue, loss of apatite, shortness of breath, joint pain, headache and fever was recovered with sequelae on an unknown date in 2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Pyrexia, SARS-CoV-2 test
Clinical narrative: Chills; Muscle pain; Chest pressure; Fatigue; Loss of apetite; Shortness of breath; Joint pain; Headache; Fever; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 24Mar2021 at 12:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation.  Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Mar2021 at 20:00 the patient experienced chills, muscle pain, chest pressure, fatigue, loss of apatite, shortness of breath, joint pain, headache and fever. On 30Mar2021, the patient underwent lab test which included COVID-19 virus test (nasal swab) and the result was found to be negative. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events chills, muscle pain, chest pressure, fatigue, loss of apatite, shortness of breath, joint pain, headache and fever was recovered with sequelae on an unknown date in 2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Parosmia
Clinical narrative: Metallic smell; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 10:30(at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included metformin (MANUFACTURER UNKNOWN), levothyroxine sodium (SYNTHROID) and QYSMIA ENGAGE started from an unknown date and for an unknown indication. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 06Apr2021 at 07:30, the patient experienced burning metallic smell, very strong metallic smell, as if it was burning metal. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event metallic smell was not resolved at the time of this report.  No follow up attempts are needed; Information about lot/batch number cannot be obtained.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Pain in extremity
Clinical narrative: Sore arm; Fever of 100.8; Headache; Chills; Fatigue; This is a spontaneous report from a contactable other healthcare professional, the patient. A 20-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the arm left on 07Apr2021 at 08:45 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. Medical history included covid-19 (Prior to the vaccination, the patient was diagnosed with COVID-19). Concomitant medication included birth control (MANUFACTURER UNKNOWN) started on unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the arm left on 16Mar2021 at 10:15 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 at 20:30 the patient experienced sore arm, fever, chills, headache, fatigue. On 07Apr2021 body temperature was checked and the result was 100.8. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event sore arm, fever, chills, headache, fatigue was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Sore arm; Fever of 100.8; Headache; Chills; Fatigue; This is a spontaneous report from a contactable other healthcare professional, the patient. A 20-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the arm left on 07Apr2021 at 08:45 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. Medical history included covid-19 (Prior to the vaccination, the patient was diagnosed with COVID-19). Concomitant medication included birth control (MANUFACTURER UNKNOWN) started on unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the arm left on 16Mar2021 at 10:15 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 at 20:30 the patient experienced sore arm, fever, chills, headache, fatigue. On 07Apr2021 body temperature was checked and the result was 100.8. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event sore arm, fever, chills, headache, fatigue was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Oral herpes
Clinical narrative: Multiple cold sores; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 05Apr2021 at 16:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety, depression and ADHD (attention deficit hyperactivity disorder). Concomitant medications included Amphetamine aspartate, Amphetamine sulfate, dexamphetamine saccharate, dexamphetamine sulfate (ADDERALL), propranolol (MANUFACTURER UNKNOWN), bupropion hydrochloride (WELLBUTRIN), butalbital, caffeine, paracetamol (FIORICET) and ethinylestradiol, levonorgestrel (OVRAL-LO), all from unknown date for unspecified indication. The patient previously took oxycodone (MANUFACTURER UNKNOWN) on an unknown date for unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021, the patient experienced multiple cold sores. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of multiple cold sores and included treatment with acyclovir (MANUFACTURER UNKNOWN) from unknown date. The clinical outcome of the event multiple cold sores was not recovered at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Lymphadenopathy, Pyrexia
Clinical narrative: Fever; Headache; Tiredness; Swollen lymph nodes under left arm, left side of neck and base of head on left side; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 10:45 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia syndrome. The patient did not receive any concomitant medications. The patient was allergic to nonsteroidal anti-inflammatory drugs (NSAIDs). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 22:00, the patient experienced fever, headache, tiredness swollen lymph nodes under left arm, left side of neck and base of head on left side for extended time (7 days). The clinical outcome of fever, headache, tiredness, swollen lymph nodes was unknown at the time of this report.  No follow up attempts are needed; Information about lot/batch number cannot be obtained.